GI Genius Module 200
Overview
The GI Genius™ intelligent endoscopy module, developed by Cosmo Artificial Intelligence – AI Ltd. and distributed worldwide by Medtronic, is the first-to-market, computer-aided polyp detection system powered by artificial intelligence (AI). It is designed to assist endoscopists in real-time detection of colonic mucosal lesions, such as polyps and adenomas, during standard white-light endoscopy examinations for screening and surveillance. The system acts as an ever-vigilant second observer, highlighting suspicious polyps with a visual marker to enhance visualization and improve detection rates. Studies have demonstrated that the GI Genius™ module can increase the Adenoma Detection Rate (ADR) by up to 14.4%, which is crucial as every 1% increase in ADR reduces the risk of colorectal cancer by 3%. The GI Genius™ system is composed of software (e.g., ColonPRO™ 4.0) and hardware (including GI Genius™ Module 100, 200, and 300), and is compatible with any colonoscope video.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Key Features
- AI-powered real-time polyp detection
- Computer-aided detection (CADe) for colonic mucosal lesions
- Enhanced visualization during colonoscopy
- Increases Adenoma Detection Rate (ADR) by up to 14.4%
- 99.7% sensitivity per lesion
- Less than 1% false positives
- Compatible with any standard white-light colonoscope video
- Highlights suspicious regions with visual markers
- Designed to host multiple AI software applications
- Assists in detection of polyps of various sizes, shapes, and morphologies
Use Cases
- Colorectal cancer screening
- Surveillance endoscopic mucosal evaluations
- Real-time assistance during colonoscopy procedures
- Detection of colonic polyps and adenomas
- Improving early detection of precancerous lesions
What Physicians Need to Know
The GI Genius™ Module 200 serves as an AI-assisted tool to enhance polyp detection during colonoscopy, acting as a "second observer." While it significantly improves adenoma detection rates, it is crucial to remember that the device is not intended to replace clinical decision-making, endoscopist assessment, or histopathological sampling. Physicians should use the visual and auditory alerts from the system to further investigate potential lesions. Be aware that the device has not been studied in patients with IBD, history of colorectal cancer, or previous colonic resection, and its performance might be affected by mucosal irregularities. Over-reliance on the system's output without maintaining a high level of clinical expertise should be avoided.
The GI Genius™ Module 200 is designed for seamless integration with existing endoscopy towers, high-definition endoscopes, video processors, and display monitors. It is compatible with major brands of endoscopic processors (Olympus, Fujifilm, Pentax) and supports various video standards including SDI, HD-SDI, and 4K UHD. Cosmo Pharmaceuticals and Medtronic are expanding their partnership to build an AI Access platform capable of hosting multiple AI-powered diagnostics from third-party developers, with NVIDIA's AI technologies being integrated to improve performance and facilitate the training and validation of new diagnostic algorithms. There are also plans to integrate the GI Genius system with Apple's Vision Pro headset for live viewing and augmented reality overlays.
Details
| Category | Gastroenterology AI |
| Pricing |
Unknown
|
| Deployment | On-premise. The GI Genius™ module is placed on a shelf of a standard endoscopy tower and connects between the video processor and the main display. It is compatible with major brands of endoscopic processors such as Olympus, Fujifilm, and Pentax. |
| Compliance | |
| BAA Available | Unknown |
| HIPAA Compliant | Unknown |
| FDA Status |
Cleared AI-estimated The GI Genius™ intelligent endoscopy module received De Novo clearance from the U.S. FDA on April 9, 2021. It was the first artificial intelligence-powered device cleared by the FDA to help identify colorectal lesions during colonoscopies. The FDA reviewed the GI Genius through the De Novo premarket review pathway, a regulatory pathway for some low- to moderate-risk devices that are novel and for which there is no legally marketed predicate device. The GI Genius™ Module 200 (GGM200.US) is part of the GI Genius system, which also includes Module 100 and ColonPRO™ 4.0 software. |
| Integrations | |
| EHR | Not specified |
| Specialties | Colorectal Surgery, Gastroenterology |
Support & Reliability
FDA clearance history
This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.
| Decision date | Number | Name as listed by FDA |
| 2024-07-25 | K241887 510(k) | GI Genius Module 200 |
What the Web Says
The GI Genius™ Module 200 is an AI-powered system designed to assist endoscopists in detecting colorectal lesions, such as polyps and adenomas, in real-time during colonoscopy procedures. It functions by analyzing video feeds from endoscopes and highlighting potentially abnormal areas with green marker squares and an alert sound. The system aims to improve detection rates and reduce the risk of missed lesions, which can contribute to the prevention of colorectal cancer. It is distributed by Medtronic and received FDA De Novo authorization in April 2021.
Overall: PositiveStrengths
- Significantly decreases the miss rate of colorectal polyps and adenomas during colonoscopy.
- Increases adenoma detection rates (ADR) by up to 14.4%.
- Helps identify small, flat polyps that might otherwise be missed by the human eye.
- Provides real-time assistance, enhancing the physician's ability to detect lesions.
- Integrates into existing endoscopy workflows without disrupting scanner protocols or requiring extensive retraining.
- High per-lesion sensitivity of 99.7% in validation studies.
Limitations
- May lead to a slight increase in biopsies that are not cancerous.
- Not intended to replace clinical decision-making.
- Not intended to be used as a stand-alone diagnostic device.
- Has not been studied in patients with Inflammatory Bowel Disease (IBD), history of CRC, or previous colonic resection.
- No data yet on whether the use of the AI module can directly reduce the risk of patients developing colorectal cancer.
- Performance may be negatively impacted if used with unvalidated equipment.
Based on reviews from: reachmd.com, pharmaphorum.com, medtronic.com, fda.gov, summitdigestive.com, healthcare-ai-consultant.com
Last updated: 2026-10-29
Ratings & Reviews
No reviews yet. Be the first to review this tool!
Rate GI Genius Module 200
Press & Coverage
Videos
Product demos, reviews, and walkthroughs for GI Genius Module 200.





